Evaxion A EVAX
NASDAQ EVAX
$3.31 +0.03 (+0.76%)
As of: Aug 21, 2026 · 2:05 PM EDT

Evaxion A (EVAX) Operating Margin Growth (1y) (2025)

Evaxion A (EVAX) Operating Margin Growth (1y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.50 Bn 131.65 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 86.10 Bn 78.10 Bn 3.93 Bn 78.00
3 Argenx Se 65.59 Bn 60.41 Bn 1.37 Bn 1,135.00
4 Moderna 56.75 Bn 51.62 Bn 52.00 Mn 7,666.00
5 BeOne Medicines 42.11 Bn 37.01 Bn 1.53 Bn 1,238.00
6 Alnylam Pharmaceuticals 31.64 Bn 28.33 Bn 992.69 Mn 2,002.00
7 BioNTech SE 27.80 Bn 9.41 Bn 668.28 Mn -3,558.00
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn 29,091.00
9 Royalty Pharma 27.29 Bn 26.45 Bn - -1,651.00
10 Evaxion A 28.11 Mn 28.11 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -875,505.00